HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Can We Stop the Current Epidemic of Blindness From Retinopathy of Prematurity?

Abstract
Retinopathy of Prematurity (ROP) is a retinal vascular disease of the premature infant. There have been significant advances in the understanding of the pathogenesis, prevention, detection and treatment of severe ROP. In developed countries, all premature infants at risk for ROP are screened routinely based on national guidelines and treatment is prompt, resulting in good visual outcomes. Blindness from ROP is a rare event in these countries. However, there is an ongoing epidemic of ROP- induced blindness in India. The reasons for this epidemic of ROP blindness are many and include increasing survival of premature infants, lack of equipment such as oxygen-blenders and pulse oximeters that are necessary for safe use of supplemental oxygen in premature infants, lack of routine screening for ROP, lack of trained personnel for ROP screening, and lack of Ophthalmologists to promptly initiate treatment when infants develop severe ROP. All the identified causes can be resolved with a concerted national co-operative effort of Pediatricians, Neonatologists, Ophthalmologists, Indian Academy of Pediatrics, National Neonatology Forum, Indian Academy of Ophthalmologists, Government of India, and parents of premature infants. We feel that tt is possible to stop the current epidemic of preventable childhood blindness from ROP with concerted action by all stakeholders.
AuthorsSourabh Dutta, Talkad Raghuveer, Anand Vinekar, Mangat Ram Dogra
JournalIndian pediatrics (Indian Pediatr) Vol. 53 Suppl 2 Pg. S80-S84 (Nov 07 2016) ISSN: 0974-7559 [Electronic] India
PMID27915311 (Publication Type: Journal Article)
Topics
  • Blindness (epidemiology, etiology, prevention & control)
  • Humans
  • India (epidemiology)
  • Infant, Newborn
  • Infant, Premature
  • Neonatal Screening
  • Practice Guidelines as Topic
  • Retinopathy of Prematurity (complications, epidemiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: